BD's outgoing diagnostic solutions and biosciences catalog brought in about $3.4 billion in 2024 sales. It will include tests for infectious disease and cervical cancer screening, as well as flow ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) announced better-than-expected revenue in Q1 CY2026, with sales up 5.2% year on year to $4.71 billion. Its non-GAAP profit of $2.90 ...

BD predicted that Hu’s experience at Lenovo will be an important advantage as technology becomes increasingly central to how ...

FRANKLIN LAKES, N.J., July 22, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Michael (Mike) Garrison has ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced that it has selected "embecta" as the name of the independent, publicly-traded company that will hold BD's ...

FRANKLIN LAKES, N.J., Dec. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C.

FRANKLIN LAKES, N.J., April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Richard (Rick) Byrd has informed ...

FRANKLIN LAKES, N.J., March 16, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company today announced that Morgan Stanley & Co. LLC ("Morgan ...

Becton Dickinson & Co. is set to make additional investments in its U.S. manufacturing network to add capacity for critical medical devices. “BD has a longstanding history as a leading U.S.

Global medtech giant BD (Becton, Dickinson and Co.) announced today it has acquired Tepha Inc., a developer and manufacturer of proprietary resorbable polymer technology. Tepha's resorbable polymer ...